000 01441 a2200385 4500
005 20250511181503.0
264 0 _c19930128
008 199301s 0 0 eng d
022 _a0269-9370
024 7 _a10.1097/00002030-199210000-00004
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGrant, M D
245 0 0 _aThe influence of lymphocyte counts and disease progression on circulating and inducible anti-HIV-1 cytotoxic T-cell activity in HIV-1-infected subjects.
_h[electronic resource]
260 _bAIDS (London, England)
_cOct 1992
300 _a1085-94 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aCD4-Positive T-Lymphocytes
_xdrug effects
650 0 4 _aCD8 Antigens
_ximmunology
650 0 4 _aCytotoxicity, Immunologic
650 0 4 _aGenes, MHC Class I
650 0 4 _aHIV Infections
_ximmunology
650 0 4 _aHIV-1
_ximmunology
650 0 4 _aHLA Antigens
_ximmunology
650 0 4 _aHumans
650 0 4 _aInterleukin-2
_xpharmacology
650 0 4 _aLymphocyte Activation
650 0 4 _aT-Lymphocyte Subsets
_xdrug effects
650 0 4 _aT-Lymphocytes
_xdrug effects
650 0 4 _aTime Factors
700 1 _aSmaill, F M
700 1 _aSingal, D P
700 1 _aRosenthal, K L
773 0 _tAIDS (London, England)
_gvol. 6
_gno. 10
_gp. 1085-94
856 4 0 _uhttps://doi.org/10.1097/00002030-199210000-00004
_zAvailable from publisher's website
999 _c1367838
_d1367838